We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$11.2B
AUM Growth
-$925M
Cap. Flow
-$880M
Cap. Flow %
-7.89%
Top 10 Hldgs %
15.04%
Holding
603
New
165
Increased
118
Reduced
122
Closed
159

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$142M
2
SWKS icon
Skyworks Solutions
SWKS
+$123M
3
EQH icon
Equitable Holdings
EQH
+$118M
4
TGT icon
Target
TGT
+$110M
5
CSCO icon
Cisco
CSCO
+$103M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$155M
2
NXPI icon
NXP Semiconductors
NXPI
+$138M
3
CRM icon
Salesforce
CRM
+$124M
4
AKAM icon
Akamai
AKAM
+$114M
5
PF
Pinnacle Foods, Inc.
PF
+$113M

Sector Composition

Rank Sector Weight
1 Technology 18.82%
2 Industrials 16.36%
3 Energy 11.6%
4 Financials 11.57%
5 Healthcare 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATXS
401
CALL
DELISTED
Astria Therapeutics
ATXS
$959K 0.01%
+16,667
New +$1.54M
DERM
402
DELISTED
Dermira, Inc.
DERM
$952K 0.01%
103,465
+3,309
+3% +$30.8K
VIVE
403
DELISTED
VIVEVE MED INC
VIVE
$876K 0.01%
322
-581
-64% -$1.67M
FSCT
404
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$857K 0.01%
25,000
-155,000
-86% -$5.04M
ECOR icon
405
electroCore
ECOR
$72.9M
$826K 0.01%
+3,337
New +$907K
CTOS icon
406
CALL
Custom Truck One Source
CTOS
$2.37B
$822K 0.01%
600,001
– –
KDMN
407
CALL
DELISTED
Kadmon Holdings, Inc.
KDMN
$798K 0.01%
200,000
– –
NBRV
408
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$765K 0.01%
880
-2,293
-72% -$2.63M
TBIO
409
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$759K 0.01%
+60,000
New +$725K
LRCX icon
410
Lam Research
LRCX
$390B
$757K 0.01%
43,810
-67,460
-61% -$1.3M
AIXC
411
AIxCrypto Holdings Inc
AIXC
$16.6M
$753K 0.01%
23
-12
-34% -$444K
TCDA
412
DELISTED
Tricida, Inc. Common Stock
TCDA
$748K 0.01%
+25,000
New +$699K
EXP icon
413
Eagle Materials
EXP
$6.57B
$741K 0.01%
7,059
-3,124
-31% -$329K
CFMS
414
DELISTED
Conformis, Inc. Common Stock
CFMS
$728K 0.01%
23,286
-12,393
-35% -$428K
FSTX
415
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$706K 0.01%
14,884
-38,595
-72% -$2.14M
NERV icon
416
Minerva Neurosciences
NERV
$199M
$692K 0.01%
10,483
+335
+3% +$20.3K
EGLT
417
CALL
DELISTED
Egalet Corporation
EGLT
$632K 0.01%
1,500,000
– –
PETX
418
DELISTED
Aratana Therapeutics, Inc.
PETX
$584K 0.01%
+137,345
New +$692K
ARDX icon
419
Ardelyx
ARDX
$997M
$543K ﹤0.01%
+146,666
New +$681K
PACK icon
420
CALL
Ranpak Holdings
PACK
$473M
$525K ﹤0.01%
+500,001
New +$4.82M
ATYR
421
aTyr Pharma
ATYR
$50.1M
$521K ﹤0.01%
40,892
-8,982
-18% -$213K
INCY icon
422
Incyte
INCY
$24.4B
$490K ﹤0.01%
7,311
-244,165
-97% -$16.7M
CDTX
423
DELISTED
Cidara Therapeutics
CDTX
$481K ﹤0.01%
4,628
-212
-4% -$20K
CDLX icon
424
Cardlytics
CDLX
$21.5M
$478K ﹤0.01%
2,199
-13,091
-86% -$2.42M
SLGL icon
425
Sol-Gel Technologies
SLGL
$288M
$474K ﹤0.01%
6,143
+197
+3% +$18K
15 16
17
18 19

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2018 Portfolio in Review

As of Q2 2018, Alyeska Investment Group held 603 positions worth $11.2B, down 7.7% from $12.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group withdrew a net $880M in Q2 2018, closing 159 positions and reducing 122 holdings. Its most notable exit was IBM, an estimated $155M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Energy.

Against the trend, Alyeska Investment Group opened a new position in Skyworks Solutions worth $122M.

  • Alyeska Investment Group's largest Q2 2018 buy was Skyworks Solutions: 1,261,692 shares worth $122M.
  • Alyeska Investment Group added most to Alphabet (Google) Class A in Q2 2018, an estimated $142M increase.
  • Alyeska Investment Group's biggest Q2 2018 reduction was Salesforce, cutting an estimated $124M.
  • Alyeska Investment Group fully exited IBM in Q2 2018, selling an estimated $155M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $11.2B portfolio in Q2 2018.
  • Alyeska Investment Group opened 165 new positions and closed 159 in Q2 2018.
  • Alyeska Investment Group's portfolio value fell 7.7% quarter-over-quarter to $11.2B.

Based on Alyeska Investment Group's 13F filing for Q2 2018, filed 14 Aug 2018.